Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1183

1.

The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: A cluster randomised trial.

von Seidlein L, Peto TJ, Landier J, Nguyen TN, Tripura R, Phommasone K, Pongvongsa T, Lwin KM, Keereecharoen L, Kajeechiwa L, Thwin MM, Parker DM, Wiladphaingern J, Nosten S, Proux S, Corbel V, Tuong-Vy N, Phuc-Nhi TL, Son DH, Huong-Thu PN, Tuyen NTK, Tien NT, Dong LT, Hue DV, Quang HH, Nguon C, Davoeung C, Rekol H, Adhikari B, Henriques G, Phongmany P, Suangkanarat P, Jeeyapant A, Vihokhern B, van der Pluijm RW, Lubell Y, White LJ, Aguas R, Promnarate C, Sirithiranont P, Malleret B, Rénia L, Onsjö C, Chan XH, Chalk J, Miotto O, Patumrat K, Chotivanich K, Hanboonkunupakarn B, Jittmala P, Kaehler N, Cheah PY, Pell C, Dhorda M, Imwong M, Snounou G, Mukaka M, Peerawaranun P, Lee SJ, Simpson JA, Pukrittayakamee S, Singhasivanon P, Grobusch MP, Cobelens F, Smithuis F, Newton PN, Thwaites GE, Day NPJ, Mayxay M, Hien TT, Nosten FH, Dondorp AM, White NJ.

PLoS Med. 2019 Feb 15;16(2):e1002745. doi: 10.1371/journal.pmed.1002745. eCollection 2019 Feb.

PMID:
30768615
2.

Plasmodium vivax relapse rates following falciparum malaria reflect previous transmission intensity.

Ashley EA, Phyo AP, Carrara VI, Tun KM, Nosten F, Smithuis F, White NJ.

J Infect Dis. 2019 Jan 29. doi: 10.1093/infdis/jiz052. [Epub ahead of print]

PMID:
30698794
3.

Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children.

Chotsiri P, Zongo I, Milligan P, Compaore YD, Somé AF, Chandramohan D, Hanpithakpong W, Nosten F, Greenwood B, Rosenthal PJ, White NJ, Ouédraogo JB, Tarning J.

Nat Commun. 2019 Jan 29;10(1):480. doi: 10.1038/s41467-019-08297-9.

4.

Collider bias and the apparent protective effect of glucose-6-phosphate dehydrogenase deficiency on cerebral malaria.

Watson JA, Leopold SJ, Simpson JA, Day NP, Dondorp AM, White NJ.

Elife. 2019 Jan 28;8. pii: e43154. doi: 10.7554/eLife.43154.

5.

A pharmacokinetic-pharmacodynamic assessment of the hepatic and bone-marrow toxicities of the new trypanoside fexinidazole.

Watson JA, Strub-Wourgraft N, Tarral A, Ribeiro I, Tarning J, White NJ.

Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.02515-18. doi: 10.1128/AAC.02515-18. [Epub ahead of print]

6.

Artemisinin Resistance and Stage Dependency of Parasite Clearance in Falciparum Malaria.

Intharabut B, Kingston HW, Srinamon K, Ashley EA, Imwong M, Dhorda M, Woodrow C, Stepniewska K, Silamut K, Day NPJ, Dondorp AM, White NJ; Tracking Resistance to Artemisinin Collaboration.

J Infect Dis. 2019 Jan 17. doi: 10.1093/infdis/jiy673. [Epub ahead of print]

PMID:
30657916
7.

Tafenoquine - A Radical Improvement?

White NJ.

N Engl J Med. 2019 Jan 17;380(3):285-286. doi: 10.1056/NEJMe1816383. No abstract available.

PMID:
30650321
8.

Martial arts technique for control of severe external bleeding.

Slevin JP, Harrison C, Da Silva E, White NJ.

Emerg Med J. 2019 Jan 5. pii: emermed-2018-207966. doi: 10.1136/emermed-2018-207966. [Epub ahead of print]

PMID:
30612092
9.

Overexpression of plasmepsin II and plasmepsin III does not directly cause reduction in Plasmodium falciparum sensitivity to artesunate, chloroquine and piperaquine.

Loesbanluechai D, Kotanan N, de Cozar C, Kochakarn T, Ansbro MR, Chotivanich K, White NJ, Wilairat P, Lee MCS, Gamo FJ, Sanz LM, Chookajorn T, Kümpornsin K.

Int J Parasitol Drugs Drug Resist. 2018 Dec 1;9:16-22. doi: 10.1016/j.ijpddr.2018.11.004. [Epub ahead of print]

10.

Identifying the components of acidosis in patients with severe P. falciparum malaria using metabolomics.

Leopold SJ, Ghose A, Allman EL, Kingston HWF, Hossain A, Dutta AK, Plewes K, Chotivanich K, Day NPJ, Tarning J, Winterberg M, White NJ, Llinás M, Dondorp AM.

J Infect Dis. 2018 Dec 19. doi: 10.1093/infdis/jiy727. [Epub ahead of print]

PMID:
30566600
11.

Point-of-care lung ultrasound for the detection of pulmonary manifestations of malaria and sepsis: An observational study.

Leopold SJ, Ghose A, Plewes KA, Mazumder S, Pisani L, Kingston HWF, Paul S, Barua A, Sattar MA, Huson MAM, Walden AP, Henwood PC, Riviello ED, Schultz MJ, Day NPJ, Kumar Dutta A, White NJ, Dondorp AM.

PLoS One. 2018 Dec 12;13(12):e0204832. doi: 10.1371/journal.pone.0204832. eCollection 2018.

12.

Perceptions of asymptomatic malaria infection and their implications for malaria control and elimination in Laos.

Adhikari B, Phommasone K, Pongvongsa T, Soundala X, Koummarasy P, Henriques G, Peto TJ, Seidlein LV, White NJ, Day NPJ, Dondorp AM, Newton PN, Cheah PY, Mayxay M, Pell C.

PLoS One. 2018 Dec 11;13(12):e0208912. doi: 10.1371/journal.pone.0208912. eCollection 2018.

13.

The origins of malaria artemisinin resistance defined by a genetic and transcriptomic background.

Zhu L, Tripathi J, Rocamora FM, Miotto O, van der Pluijm R, Voss TS, Mok S, Kwiatkowski DP, Nosten F, Day NPJ, White NJ, Dondorp AM, Bozdech Z; Tracking Resistance to Artemisinin Collaboration I.

Nat Commun. 2018 Dec 4;9(1):5158. doi: 10.1038/s41467-018-07588-x.

14.

The contribution of asymptomatic Plasmodium infections to the transmission of malaria in Kayin state, Myanmar.

Chaumeau V, Kajeechiwa L, Fustec B, Landier J, Nyo SN, Hsel SN, Phatharakokordbun P, Kittiphanakun P, Nosten S, Thwin MM, Tun SW, Wiladphaingern J, Cottrell G, Parker DM, Minh MC, Kwansomboon N, Metaane S, Montazeau C, Kunjanwong K, Sawasdichai S, Andolina C, Ling C, Haohankhunnatham W, Christiensen P, Wanyatip S, Konghahong K, Cerqueira D, Imwong M, Dondorp AM, Chareonviriyaphap T, White NJ, Nosten FH, Corbel V.

J Infect Dis. 2018 Nov 29. doi: 10.1093/infdis/jiy686. [Epub ahead of print]

PMID:
30500927
15.

Real time PCR detection of common CYP2D6 genetic variants and its application in a Karen population study.

Puaprasert K, Chu C, Saralamba N, Day NPJ, Nosten F, White NJ, Dondorp AM, Imwong M.

Malar J. 2018 Nov 15;17(1):427. doi: 10.1186/s12936-018-2579-8.

16.

The arrhythmogenic cardiotoxicity of the quinoline and structurally related antimalarial drugs: a systematic review.

Haeusler IL, Chan XHS, Guérin PJ, White NJ.

BMC Med. 2018 Nov 7;16(1):200. doi: 10.1186/s12916-018-1188-2.

17.

The dynamic of asymptomatic Plasmodium falciparum infections following mass drug administrations with dihydroarteminisin-piperaquine plus a single low dose of primaquine in Savannakhet Province, Laos.

Pongvongsa T, Phommasone K, Adhikari B, Henriques G, Chotivanich K, Hanboonkunupakarn B, Mukaka M, Peerawaranun P, von Seidlein L, Day NPJ, White NJ, Dondorp AM, Imwong M, Newton PN, Singhasivanon P, Mayxay M, Pukrittayakamee S.

Malar J. 2018 Nov 3;17(1):405. doi: 10.1186/s12936-018-2541-9.

18.

Malaria elimination in remote communities requires integration of malaria control activities into general health care: an observational study and interrupted time series analysis in Myanmar.

McLean ARD, Wai HP, Thu AM, Khant ZS, Indrasuta C, Ashley EA, Kyaw TT, Day NPJ, Dondorp A, White NJ, Smithuis FM.

BMC Med. 2018 Oct 22;16(1):183. doi: 10.1186/s12916-018-1172-x.

19.

Anaemia and malaria.

White NJ.

Malar J. 2018 Oct 19;17(1):371. doi: 10.1186/s12936-018-2509-9. Review.

20.

Asymptomatic Natural Human Infections With the Simian Malaria Parasites Plasmodium cynomolgi and Plasmodium knowlesi.

Imwong M, Madmanee W, Suwannasin K, Kunasol C, Peto TJ, Tripura R, von Seidlein L, Nguon C, Davoeung C, Day NPJ, Dondorp AM, White NJ.

J Infect Dis. 2019 Feb 15;219(5):695-702. doi: 10.1093/infdis/jiy519.

PMID:
30295822
21.

Microvesicles from malaria-infected red blood cells activate natural killer cells via MDA5 pathway.

Ye W, Chew M, Hou J, Lai F, Leopold SJ, Loo HL, Ghose A, Dutta AK, Chen Q, Ooi EE, White NJ, Dondorp AM, Preiser P, Chen J.

PLoS Pathog. 2018 Oct 4;14(10):e1007298. doi: 10.1371/journal.ppat.1007298. eCollection 2018 Oct.

22.

Fitness Loss under Amino Acid Starvation in Artemisinin-Resistant Plasmodium falciparum Isolates from Cambodia.

Bunditvorapoom D, Kochakarn T, Kotanan N, Modchang C, Kümpornsin K, Loesbanluechai D, Krasae T, Cui L, Chotivanich K, White NJ, Wilairat P, Miotto O, Chookajorn T.

Sci Rep. 2018 Aug 22;8(1):12622. doi: 10.1038/s41598-018-30593-5.

23.

Enantiospecific pharmacokinetics and drug-drug interactions of primaquine and blood-stage antimalarial drugs.

Chairat K, Jittamala P, Hanboonkunupakarn B, Pukrittayakamee S, Hanpithakpong W, Blessborn D, White NJ, Day NPJ, Tarning J.

J Antimicrob Chemother. 2018 Nov 1;73(11):3102-3113. doi: 10.1093/jac/dky297.

24.

The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis.

Commons RJ, Simpson JA, Thriemer K, Humphreys GS, Abreha T, Alemu SG, Añez A, Anstey NM, Awab GR, Baird JK, Barber BE, Borghini-Fuhrer I, Chu CS, D'Alessandro U, Dahal P, Daher A, de Vries PJ, Erhart A, Gomes MSM, Gonzalez-Ceron L, Grigg MJ, Heidari A, Hwang J, Kager PA, Ketema T, Khan WA, Lacerda MVG, Leslie T, Ley B, Lidia K, Monteiro WM, Nosten F, Pereira DB, Phan GT, Phyo AP, Rowland M, Saravu K, Sibley CH, Siqueira AM, Stepniewska K, Sutanto I, Taylor WRJ, Thwaites G, Tran BQ, Tran HT, Valecha N, Vieira JLF, Wangchuk S, William T, Woodrow CJ, Zuluaga-Idarraga L, Guerin PJ, White NJ, Price RN.

Lancet Infect Dis. 2018 Sep;18(9):1025-1034. doi: 10.1016/S1473-3099(18)30348-7. Epub 2018 Jul 20.

25.

Epidemiology of Plasmodium vivax Malaria Infection in Nepal.

Rijal KR, Adhikari B, Ghimire P, Banjara MR, Hanboonkunupakarn B, Imwong M, Chotivanich K, Ceintury KP, Lal BK, Das Thakur G, Day NPJ, White NJ, Pukrittayakamee S.

Am J Trop Med Hyg. 2018 Sep;99(3):680-687. doi: 10.4269/ajtmh.18-0373. Epub 2018 Jul 12.

26.

Genetic polymorphisms in the circumsporozoite protein of Plasmodium malariae show a geographical bias.

Saralamba N, Mayxay M, Newton PN, Smithuis F, Nosten F, Archasuksan L, Pukrittayakamee S, White NJ, Day NPJ, Dondorp AM, Imwong M.

Malar J. 2018 Jul 16;17(1):269. doi: 10.1186/s12936-018-2413-3.

27.

Effectiveness and safety of 3 and 5 day courses of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in an area of emerging artemisinin resistance in Myanmar.

Tun KM, Jeeyapant A, Myint AH, Kyaw ZT, Dhorda M, Mukaka M, Cheah PY, Imwong M, Hlaing T, Kyaw TH, Ashley EA, Dondorp A, White NJ, Day NPJ, Smithuis F.

Malar J. 2018 Jul 11;17(1):258. doi: 10.1186/s12936-018-2404-4.

28.

Thromboelastometric prediction of mortality using the kinetics of clot growth in critically ill septic patients.

Scărlătescu E, Lancé MD, White NJ, Tomescu DR.

Blood Coagul Fibrinolysis. 2018 Sep;29(6):533-539. doi: 10.1097/MBC.0000000000000757.

PMID:
29985193
29.

Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia.

Henriques G, Phommasone K, Tripura R, Peto TJ, Raut S, Snethlage C, Sambo I, Sanann N, Nguon C, Adhikari B, Pongvongsa T, Imwong M, von Seidlein L, Day NP, White NJ, Dondorp AM, Newton P, Ley B, Mayxay M.

Malar J. 2018 Jun 22;17(1):243. doi: 10.1186/s12936-018-2390-6.

30.

Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis.

Kloprogge F, Workman L, Borrmann S, Tékété M, Lefèvre G, Hamed K, Piola P, Ursing J, Kofoed PE, Mårtensson A, Ngasala B, Björkman A, Ashton M, Friberg Hietala S, Aweeka F, Parikh S, Mwai L, Davis TME, Karunajeewa H, Salman S, Checchi F, Fogg C, Newton PN, Mayxay M, Deloron P, Faucher JF, Nosten F, Ashley EA, McGready R, van Vugt M, Proux S, Price RN, Karbwang J, Ezzet F, Bakshi R, Stepniewska K, White NJ, Guerin PJ, Barnes KI, Tarning J.

PLoS Med. 2018 Jun 12;15(6):e1002579. doi: 10.1371/journal.pmed.1002579. eCollection 2018 Jun.

31.

Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria.

Chu CS, Phyo AP, Lwin KM, Win HH, San T, Aung AA, Raksapraidee R, Carrara VI, Bancone G, Watson J, Moore KA, Wiladphaingern J, Proux S, Sriprawat K, Winterberg M, Cheah PY, Chue AL, Tarning J, Imwong M, Nosten F, White NJ.

Clin Infect Dis. 2018 Oct 30;67(10):1543-1549. doi: 10.1093/cid/ciy319.

32.

Risk of sudden unexplained death after use of dihydroartemisinin-piperaquine for malaria: a systematic review and Bayesian meta-analysis.

Chan XHS, Win YN, Mawer LJ, Tan JY, Brugada J, White NJ.

Lancet Infect Dis. 2018 Aug;18(8):913-923. doi: 10.1016/S1473-3099(18)30297-4. Epub 2018 Jun 18. Erratum in: Lancet Infect Dis. 2018 Jun 26;:.

33.

Association of the Quick Sequential (Sepsis-Related) Organ Failure Assessment (qSOFA) Score With Excess Hospital Mortality in Adults With Suspected Infection in Low- and Middle-Income Countries.

Rudd KE, Seymour CW, Aluisio AR, Augustin ME, Bagenda DS, Beane A, Byiringiro JC, Chang CH, Colas LN, Day NPJ, De Silva AP, Dondorp AM, Dünser MW, Faiz MA, Grant DS, Haniffa R, Van Hao N, Kennedy JN, Levine AC, Limmathurotsakul D, Mohanty S, Nosten F, Papali A, Patterson AJ, Schieffelin JS, Shaffer JG, Thuy DB, Thwaites CL, Urayeneza O, White NJ, West TE, Angus DC; Sepsis Assessment and Identification in Low Resource Settings (SAILORS) Collaboration.

JAMA. 2018 Jun 5;319(21):2202-2211. doi: 10.1001/jama.2018.6229.

34.

Infectivity of Chronic Malaria Infections and Its Consequences for Control and Elimination.

Aguas R, Maude RJ, Gomes MGM, White LJ, White NJ, Dondorp AM.

Clin Infect Dis. 2018 Jul 2;67(2):295-302. doi: 10.1093/cid/ciy055.

35.

Plasmepsin II-III copy number accounts for bimodal piperaquine resistance among Cambodian Plasmodium falciparum.

Bopp S, Magistrado P, Wong W, Schaffner SF, Mukherjee A, Lim P, Dhorda M, Amaratunga C, Woodrow CJ, Ashley EA, White NJ, Dondorp AM, Fairhurst RM, Ariey F, Menard D, Wirth DF, Volkman SK.

Nat Commun. 2018 May 2;9(1):1769. doi: 10.1038/s41467-018-04104-z.

36.

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.

Watson J, Taylor WRJ, Bancone G, Chu CS, Jittamala P, White NJ.

PLoS Negl Trop Dis. 2018 Apr 20;12(4):e0006440. doi: 10.1371/journal.pntd.0006440. eCollection 2018 Apr.

37.

Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: Divergent policies and practices in malaria endemic countries.

Recht J, Ashley EA, White NJ.

PLoS Negl Trop Dis. 2018 Apr 19;12(4):e0006230. doi: 10.1371/journal.pntd.0006230. eCollection 2018 Apr. Review.

38.

TEG Lysis Shutdown Represents Coagulopathy in Bleeding Trauma Patients: Analysis of the PROPPR Cohort.

Cardenas JC, Wade CE, Cotton BA, George MJ, Holcomb JB, Schreiber MA, White NJ; PROPPR Study Group.

Shock. 2019 Mar;51(3):273-283. doi: 10.1097/SHK.0000000000001160.

PMID:
29664836
39.

Characterizing Blood-Stage Antimalarial Drug MIC Values In Vivo Using Reinfection Patterns.

Watson J, Chu CS, Tarning J, White NJ.

Antimicrob Agents Chemother. 2018 Jun 26;62(7). pii: e02476-17. doi: 10.1128/AAC.02476-17. Print 2018 Jul.

40.

Primaquine Pharmacokinetics in Lactating Women and Breastfed Infant Exposures.

Gilder ME, Hanpithakphong W, Hoglund RM, Tarning J, Win HH, Hilda N, Chu CS, Bancone G, Carrara VI, Singhasivanon P, White NJ, Nosten F, McGready R.

Clin Infect Dis. 2018 Sep 14;67(7):1000-1007. doi: 10.1093/cid/ciy235.

41.

Platelets loaded with liposome-encapsulated thrombin have increased coagulability.

Chan V, Sarkari M, Sunderland R, St John AE, White NJ, Kastrup CJ.

J Thromb Haemost. 2018 Jun;16(6):1226-1235. doi: 10.1111/jth.14006. Epub 2018 Apr 20.

PMID:
29573326
42.

Acidosis and acute kidney injury in severe malaria.

Sriboonvorakul N, Ghose A, Hassan MMU, Hossain MA, Faiz MA, Pukrittayakamee S, Chotivanich K, Sukthana Y, Leopold SJ, Plewes K, Day NPJ, White NJ, Tarning J, Dondorp AM.

Malar J. 2018 Mar 23;17(1):128. doi: 10.1186/s12936-018-2274-9.

43.

Damage Control Resuscitation Supplemented with Vasopressin in a Severe Polytrauma Model with Traumatic Brain Injury and Uncontrolled Internal Hemorrhage.

Dickson JM, Wang X, St John AE, Lim EB, Stern SA, White NJ.

Mil Med. 2018 Mar 14. doi: 10.1093/milmed/usy001. [Epub ahead of print]

PMID:
29547998
44.

Acetaminophen as a Renoprotective Adjunctive Treatment in Patients With Severe and Moderately Severe Falciparum Malaria: A Randomized, Controlled, Open-Label Trial.

Plewes K, Kingston HWF, Ghose A, Wattanakul T, Hassan MMU, Haider MS, Dutta PK, Islam MA, Alam S, Jahangir SM, Zahed ASM, Sattar MA, Chowdhury MAH, Herdman MT, Leopold SJ, Ishioka H, Piera KA, Charunwatthana P, Silamut K, Yeo TW, Lee SJ, Mukaka M, Maude RJ, Turner GDH, Faiz MA, Tarning J, Oates JA, Anstey NM, White NJ, Day NPJ, Hossain MA, Roberts Ii LJ, Dondorp AM.

Clin Infect Dis. 2018 Sep 14;67(7):991-999. doi: 10.1093/cid/ciy213.

45.

A Controlled Trial of Mass Drug Administration to Interrupt Transmission of Multidrug-Resistant Falciparum Malaria in Cambodian Villages.

Tripura R, Peto TJ, Chea N, Chan D, Mukaka M, Sirithiranont P, Dhorda M, Promnarate C, Imwong M, von Seidlein L, Duanguppama J, Patumrat K, Huy R, Grobusch MP, Day NPJ, White NJ, Dondorp AM.

Clin Infect Dis. 2018 Aug 31;67(6):817-826. doi: 10.1093/cid/ciy196.

46.

An inventory of supranational antimicrobial resistance surveillance networks involving low- and middle-income countries since 2000.

Ashley EA, Recht J, Chua A, Dance D, Dhorda M, Thomas NV, Ranganathan N, Turner P, Guerin PJ, White NJ, Day NP.

J Antimicrob Chemother. 2018 Jul 1;73(7):1737-1749. doi: 10.1093/jac/dky026.

47.

Primaquine-induced haemolysis in females heterozygous for G6PD deficiency.

Chu CS, Bancone G, Nosten F, White NJ, Luzzatto L.

Malar J. 2018 Mar 2;17(1):101. doi: 10.1186/s12936-018-2248-y. Review.

48.

Clot structure predicts recurrent thrombosis.

White NJ.

Blood. 2018 Feb 15;131(7):715-716. doi: 10.1182/blood-2018-01-824169. No abstract available.

49.

Drugs that reduce transmission of falciparum malaria.

Price RN, White NJ.

Lancet Infect Dis. 2018 Jun;18(6):585-586. doi: 10.1016/S1473-3099(18)30070-7. Epub 2018 Feb 6. No abstract available.

50.

The persistence and oscillations of submicroscopic Plasmodium falciparum and Plasmodium vivax infections over time in Vietnam: an open cohort study.

Nguyen TN, von Seidlein L, Nguyen TV, Truong PN, Hung SD, Pham HT, Nguyen TU, Le TD, Dao VH, Mukaka M, Day NP, White NJ, Dondorp AM, Thwaites GE, Hien TT.

Lancet Infect Dis. 2018 May;18(5):565-572. doi: 10.1016/S1473-3099(18)30046-X. Epub 2018 Feb 2. Erratum in: Lancet Infect Dis. 2018 May;18(5):492.

Supplemental Content

Loading ...
Support Center